H. Ahlert

Dominant TNFα and impaired IL‐2 cytokine profiles of CD4+ T cells from children with type‐1 diabetes

K. Köhrer, M. Jacobsen, E. Mayatepek, 2017, Immunology and cell biology.

Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response.

H. Gohlke, A. Borkhardt, F. Hansen, 2018, Blood.

Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.

A. Borkhardt, D. Christianson, F. Hansen, 2018, Journal of medicinal chemistry.

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

A. Letai, C. Schmitt, L. Pasqualucci, 2020, Blood cancer discovery.

4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads.

A. Borkhardt, S. Günther, F. Hansen, 2021, Journal of medicinal chemistry.

CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility

M. Roden, M. Jacobsen, E. Mayatepek, 2018, Molecular and Cellular Pediatrics.

Interleukin‐7 receptor α‐chain haplotypes differentially affect soluble IL‐7 receptor and IL‐7 serum concentrations in children with type 1 diabetes

M. Roden, M. Jacobsen, E. Mayatepek, 2018, Pediatric diabetes.